Susquehanna International Group’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-44,500
| Closed | -$3.02M | – | 11212 |
|
|
2019
Q3 | $3.02M | Buy |
44,500
+19,300
| +77% | +$1.33M | ﹤0.01% | 3479 |
|
|
2019
Q2 | $1.47M | Sell |
25,200
-28,100
| -53% | -$1.66M | ﹤0.01% | 4824 |
|
|
2019
Q1 | $3.73M | Buy |
53,300
+36,100
| +210% | +$2.68M | ﹤0.01% | 2825 |
|
|
2018
Q4 | $1.11M | Sell |
17,200
-10,000
| -37% | -$701K | ﹤0.01% | 4485 |
|
|
2018
Q3 | $1.91M | Buy |
27,200
+21,800
| +404% | +$1.28M | ﹤0.01% | 4082 |
|
|
2018
Q2 | $272K | Buy |
+5,400
| New | +$214K | ﹤0.01% | 8039 |
|
|
2018
Q1 | – | Sell |
-5,900
| Closed | -$202K | – | 10641 |
|
|
2017
Q4 | $202K | Buy |
+5,900
| New | +$188K | ﹤0.01% | 8276 |
|
|
2016
Q4 | – | Sell |
-7,600
| Closed | -$220K | – | 10438 |
|
|
2016
Q3 | $220K | Sell |
7,600
-6,800
| -47% | -$189K | ﹤0.01% | 7437 |
|
|
2016
Q2 | $373K | Buy |
+14,400
| New | +$382K | ﹤0.01% | 6619 |
|
|
2015
Q2 | – | Sell |
-277,700
| Closed | -$8.48M | – | 10649 |
|
|
2015
Q1 | $8.48M | Buy |
+277,700
| New | +$8.83M | ﹤0.01% | 2051 |
|
|
2014
Q3 | – | Sell |
-10,400
| Closed | -$285K | – | 10210 |
|
|
2014
Q2 | $285K | Sell |
10,400
-294,500
| -97% | -$7.84M | ﹤0.01% | 8474 |
|
|
2014
Q1 | $8.03M | Buy |
304,900
+265,900
| +682% | +$7.63M | ﹤0.01% | 2269 |
|
|
2013
Q4 | $1.14M | Buy |
39,000
+8,400
| +27% | +$267K | ﹤0.01% | 5272 |
|
|
2013
Q3 | $936K | Sell |
30,600
-17,900
| -37% | -$599K | ﹤0.01% | 5389 |
|
|
2013
Q2 | $1.54M | Buy |
+48,500
| New | +$1.59M | ﹤0.01% | 4321 |
|
Susquehanna International Group's GHDX Position: Q4 2019 in Review
Susquehanna International Group sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 40,472 shares — an estimated $2.75M sold.
Susquehanna International Group first reported a position in GHDX in Q1 2014 and held it in 14 quarters. The position peaked at $2.87M in Q2 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Susquehanna International Group reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Susquehanna International Group sold 40,472 Genomic Health, Inc. shares in Q4 2019, an estimated $2.75M.
- Susquehanna International Group first reported a position in Genomic Health, Inc. in Q1 2014 and held it in 14 quarters.
- Susquehanna International Group's Genomic Health, Inc. position peaked at $2.87M in Q2 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.